848063016	848063016	CD	B-NP	O
|	|	JJ	I-NP	O
S	S	NN	I-NP	O
|	|	NN	I-NP	O
53811923	53811923	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
190664	190664	CD	B-NP	O
|	|	CC	I-NP	O
10/20/1996	10/20/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/21/1996	7/21/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/1/1996	10/1/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
DYSPNEA	DYSPNEA	NN	B-NP	O
ON	ON	NNP	I-NP	O
EXERTION	EXERTION	NNP	I-NP	O
,	,	,	O	O
KNOWN	KNOWN	NNP	B-NP	O
CORONARY	CORONARY	NNP	I-NP	O
ARTERY	ARTERY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
known	know	VBN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
exertional	exertional	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
his	his	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
laser	laser	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
occluded	occlude	VBN	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
January	January	NNP	B-NP	O
1995	1995	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
demonstrated	demonstrate	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
artery	artery	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
heavily	heavily	RB	I-VP	O
calcified	calcify	VBN	I-VP	O
and	and	CC	O	O
not	not	RB	O	O
amenable	amenable	JJ	B-ADJP	O
to	to	TO	B-VP	O
balloon	balloon	VB	I-VP	O
angioplasty	angioplasty	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
six	six	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
or	or	CC	I-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
exercise	exercise	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
nitro	nitro	NN	B-NP	O
patch	patch	NN	I-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
Verapamil	Verapamil	NNP	B-NP	O
SR	SR	NNP	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
high	high	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
exercising	exercise	VBG	I-VP	O
as	as	RB	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
used	use	VBD	B-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
regimen	regimen	NN	I-NP	O
usually	usually	RB	B-ADVP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
ski	ski	NN	I-NP	O
machine	machine	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
some	some	DT	B-NP	O
exertional	exertional	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
has	have	VBZ	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
meal	meal	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
lying	lie	VBG	I-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
probably	probably	RB	B-ADVP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
increasing	increase	VBG	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
dyspneic	dyspneic	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
contacted	contact	VBD	B-VP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Jared	Jared	NNP	B-NP	O
Stockel	Stockel	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
probably	probably	RB	B-ADVP	O
needed	need	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
attempted	attempt	VBN	I-NP	O
laser	laser	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
occluded	occlude	VBN	I-NP	O
left	leave	VBD	B-VP	O
circumflex	circumflex	NN	B-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Verapamil	Verapamil	NNP	B-NP	O
SR	SR	NNP	I-NP	O
240	240	CD	I-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	I-NP	O
K-Dur	K-Dur	NNP	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
nitro	nitro	NN	B-NP	O
patch	patch	NN	I-NP	O
0.2	0.2	CD	B-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
patches	patch	NNS	I-NP	O
times	times	CC	O	O
two	two	CD	B-NP	O
hours	hour	NNS	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
52	52	CD	B-NP	O
and	and	CC	O	O
regular	regular	JJ	B-ADJP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
160/94	160/94	CD	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
ECG	ECG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
at	at	IN	B-PP	O
56	56	CD	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
vesicular	vesicular	JJ	I-NP	O
block	block	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

SMA-7	SMA-7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
high	high	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
1.7	1.7	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
3.1	3.1	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
CBC	CBC	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
PT/PTT	PT/PTT	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
known	known	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
etiology	etiology	NN	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
NY	NY	NNP	I-NP	O
team	team	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
4	4	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
22	22	CD	B-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
fatigue	fatigue	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
nonspecific	nonspecific	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
ECG	ECG	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
MIBI	MIBI	NNP	I-NP	O
images	image	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
inferolateral	inferolateral	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
laser	laser	NN	B-NP	O
assisted	assist	VBD	B-VP	O
PTCA	PTCA	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
post	post	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
increased	increase	VBN	B-NP	O
bleeding	bleeding	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
groin	groin	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
versus	versus	IN	B-PP	O
pseudoaneurysm	pseudoaneurysm	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
bruit	bruit	NN	I-NP	O
was	be	VBD	B-VP	O
heard	hear	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
pseudoaneurysm	pseudoaneurysm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
overnight	overnight	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
8/26/96	8/26/96	CD	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
manipulated	manipulate	VBN	I-VP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
outpatient	outpatient	NN	I-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
which	which	WDT	B-NP	O
grew	grow	VBD	B-VP	O
alpha	alpha	NN	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
pen-VK	pen-VK	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
A1C	A1C	NN	I-NP	I-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
7	7	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
this	this	DT	B-NP	O
and	and	CC	O	O
refused	refuse	VBD	B-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
important	important	JJ	I-ADJP	O
for	for	IN	B-SBAR	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	I-NP	O
cardiac	cardiac	JJ	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
juncture	juncture	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
issue	issue	NN	I-NP	O
of	of	IN	B-PP	O
restarting	restart	VBG	B-VP	O
glyburide	glyburide	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
brought	bring	VBN	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Boncella	Boncella	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
today	today	NN	B-NP	O
,	,	,	O	O
August	August	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
medicine	medicine	NN	B-NP	O
compliance	compliance	NN	I-NP	O
and	and	CC	O	O
measure	measure	NN	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Adalat	Adalat	NN	B-NP	O
CC	CC	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
sublingually	sublingually	RB	B-NP	O
q.	q.	RB	I-NP	O
5	5	CD	I-NP	O
minutes	minute	NNS	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pen-VK	pen-VK	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
times	time	NNS	I-NP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
JAMEY	JAMEY	NNP	B-NP	O
QUENTIN	QUENTIN	NNP	I-NP	O
GROPPER	GROPPER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
KV71	KV71	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SAMMIE	SAMMIE	NNP	B-NP	O
E.	E.	NNP	I-NP	O
LOBAUGH	LOBAUGH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LY3	LY3	NNP	I-NP	O
YM805/0472	YM805/0472	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
76366	76366	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

R7BDIYYMD	R7BDIYYMD	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
8/26/96	8/26/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/18/96	8/18/96	CD	B-NP	O

